At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 20 enrolled
Drug / intervention
Santyl +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of SANTYL vs. Hydrogel in Debridement of Inflamed Diabetic Foot Ulcers
In Brief
A Phase 4 clinical trial evaluating Santyl and Tegaderm Hydrogel for Diabetic Foot Ulcers. Completed, enrolled 20 participants across 1 site.
Detailed Summary
This study compares two standard methods for cleaning the surface of wounds on the feet of patients with diabetes mellitus. The question being asked is whether inflammation of the wound affects the ability of one or both of the methods to work.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Foot Ulcers
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 2010
Enrollment StartJul 2010
Primary CompletionOct 2011
Study CompletionOct 2012
TodayJul 2026
First PostedJun 14, 2010
Enrollment StartJul 1, 2010
Primary CompletionOct 1, 2011
Study CompletionOct 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 16.1 years ago
Interventions
Santyldrug
Apply one 24-hr period sufficient to cover the wound.
Tegaderm Hydrogeldrug
Apply once 24-hr period sufficient to cover the wound.